{"id":"https://openalex.org/W2100567310","doi":"https://doi.org/10.1177/0961203312442260","title":"Anti-cardiolipin and anti-\u03b22-glycoprotein I antibodies: normal reference ranges in northwestern Italy","display_name":"Anti-cardiolipin and anti-\u03b22-glycoprotein I antibodies: normal reference ranges in northwestern Italy","publication_year":2012,"publication_date":"2012-05-25","ids":{"openalex":"https://openalex.org/W2100567310","doi":"https://doi.org/10.1177/0961203312442260","mag":"2100567310","pmid":"https://pubmed.ncbi.nlm.nih.gov/22635238"},"language":"en","primary_location":{"id":"doi:10.1177/0961203312442260","doi":"https://doi.org/10.1177/0961203312442260","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0961203312442260","pdf_url":null,"source":{"id":"https://openalex.org/S115920904","display_name":"Lupus","issn_l":"0961-2033","issn":["0961-2033","1477-0962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080007446","display_name":"Barbara Montaruli","orcid":"https://orcid.org/0000-0002-5713-2069","observed_orcids":["https://orcid.org/0000-0002-5713-2069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Montaruli","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029859639","display_name":"E De Luna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E De Luna","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015238111","display_name":"Giulio Mengozzi","orcid":"https://orcid.org/0000-0003-0431-8369","observed_orcids":["https://orcid.org/0000-0003-0431-8369"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Mengozzi","raw_affiliation_strings":["GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047035994","display_name":"Filippo Molinari","orcid":"https://orcid.org/0000-0003-1150-2244","observed_orcids":["https://orcid.org/0000-0003-1150-2244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Molinari","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050269290","display_name":"E Napolitano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Napolitano","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109434146","display_name":"Patrizia Napoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Napoli","raw_affiliation_strings":["GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905146","display_name":"C. Nicol\u00f2","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Nicolo","raw_affiliation_strings":["GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113817057","display_name":"Alessandra Romito","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Romito","raw_affiliation_strings":["GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052162438","display_name":"Stefania Stella","orcid":"https://orcid.org/0000-0002-7189-2312","observed_orcids":["https://orcid.org/0000-0002-7189-2312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Stella","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055853592","display_name":"M. Bazzan","orcid":"https://orcid.org/0000-0002-1451-1368","observed_orcids":["https://orcid.org/0000-0002-1451-1368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Bazzan","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081488567","display_name":"MT Bertero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MT Bertero","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044417475","display_name":"RENATO CARIGNOLA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Carignola","raw_affiliation_strings":["Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109281959","display_name":"Cristiana A. Marchese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Marchese","raw_affiliation_strings":["GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy","Regional Network for Rare Diseases. APS Piedmont Consortium, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GAL (Gruppo Autoimmunita\u2019 di Laboratorio del Piemonte e della Valle d\u2019Aosta), Italy","institution_ids":[]},{"raw_affiliation_string":"Regional Network for Rare Diseases. APS Piedmont Consortium, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.2001,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.5988678,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"21","issue":"7","first_page":"799","last_page":"801"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticardiolipin-antibodies","display_name":"anticardiolipin antibodies","score":0.9259999990463257},{"id":"https://openalex.org/keywords/anti-beta2-glycoprotein-i-antibodies","display_name":"anti-beta2-glycoprotein I antibodies","score":0.9850000143051147},{"id":"https://openalex.org/keywords/reference-values","display_name":"reference values","score":0.7400000095367432},{"id":"https://openalex.org/keywords/antiphospholipid-syndrome","display_name":"antiphospholipid syndrome","score":0.7870000004768372},{"id":"https://openalex.org/keywords/analytical-performance","display_name":"analytical performance","score":0.6069999933242798},{"id":"https://openalex.org/keywords/igg-and-igm-antibodies","display_name":"IgM and IgG antibodies","score":0.7009999752044678},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.6000000238418579},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.6309999823570251},{"id":"https://openalex.org/keywords/commercial-elisa-kits","display_name":"commercial ELISA kits","score":0.609000027179718},{"id":"https://openalex.org/keywords/northwestern-italy","display_name":"northwestern Italy","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8162134885787964},{"id":"https://openalex.org/C2778143274","wikidata":"https://www.wikidata.org/wiki/Q1626599","display_name":"Reference range","level":2,"score":0.6983045339584351},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.6580016613006592},{"id":"https://openalex.org/C2776874634","wikidata":"https://www.wikidata.org/wiki/Q582207","display_name":"Antiphospholipid syndrome","level":3,"score":0.6345704793930054},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5941306948661804},{"id":"https://openalex.org/C122048520","wikidata":"https://www.wikidata.org/wiki/Q2913954","display_name":"Percentile","level":2,"score":0.5693824887275696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5254567861557007},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.5061208605766296},{"id":"https://openalex.org/C2985213535","wikidata":"https://www.wikidata.org/wiki/Q1626599","display_name":"Reference values","level":2,"score":0.49404314160346985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4072127640247345},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35186439752578735},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007075","descriptor_name":"Immunoglobulin M","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017153","descriptor_name":"Antibodies, Anticardiolipin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D053482","descriptor_name":"beta 2-Glycoprotein I","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/0961203312442260","doi":"https://doi.org/10.1177/0961203312442260","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0961203312442260","pdf_url":null,"source":{"id":"https://openalex.org/S115920904","display_name":"Lupus","issn_l":"0961-2033","issn":["0961-2033","1477-0962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus","raw_type":"journal-article"},{"id":"pmid:22635238","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22635238","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.847.4835","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.847.4835","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://lup.sagepub.com/content/21/7/799.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1668264153","https://openalex.org/W2015068969","https://openalex.org/W2024895442","https://openalex.org/W2035922913","https://openalex.org/W2050209643","https://openalex.org/W2054330426","https://openalex.org/W2081049472","https://openalex.org/W2097468114","https://openalex.org/W4323283585"],"related_works":["https://openalex.org/W7099938422","https://openalex.org/W2317132554","https://openalex.org/W7160507653","https://openalex.org/W4410421503","https://openalex.org/W4396559584","https://openalex.org/W2152100242","https://openalex.org/W3007052875","https://openalex.org/W7096139137","https://openalex.org/W2154355531","https://openalex.org/W2801524617"],"abstract_inverted_index":{"Laboratory":[0,128],"tests":[1],"for":[2,27,51,188],"anticardiolipin":[3],"antibodies":[4,9],"(aCL)":[5],"and":[6,24,53,60,78,100,119,125,146,175,190,208],"anti-\u03b22glycoprotein":[7],"I":[8],"(a-\u03b22GPI)":[10],"face":[11],"problems":[12],"common":[13],"to":[14,30,41,61,153],"many":[15],"autoantibody":[16],"assays:":[17],"the":[18,25,38,43,56,63,70,107,155,159,169,177,181,195,203],"lack":[19],"of":[20,37,58,66,89,158,205],"a":[21,87],"reference":[22,44,73,185],"standard":[23],"need":[26],"each":[28],"laboratory":[29,198],"assess":[31],"assay-specific":[32],"cut-off":[33,161],"values.":[34],"The":[35],"aims":[36],"study":[39],"were":[40,151],"evaluate":[42],"range":[45,164],"upper":[46,165],"limits":[47,166],"(99th":[48],"percentile)":[49],"used":[50],"aCL":[52,77,192],"a-\u03b22GPI":[54,79],"in":[55,80,111,202],"northwest":[57],"Italy":[59],"investigate":[62,154],"analytical":[64,156],"performances":[65],"these":[67],"assays":[68,109,174],"with":[69,168],"newly":[71],"obtained":[72,160,167],"ranges.":[74],"We":[75,104],"assayed":[76],"104":[81],"serum":[82,133],"samples":[83],"from":[84,137,141,148,176,194],"patients":[85,145,150],"without":[86],"history":[88],"thrombosis,":[90],"pregnancy":[91],"morbidity,":[92],"tumours,":[93],"infections":[94],"and/or":[95],"autoimmune":[96],"diseases":[97],"(30":[98],"males":[99],"74":[101],"non-pregnant":[102],"females).":[103],"tested":[105],"all":[106],"commercial":[108,170],"available":[110],"our":[112],"regions":[113],"(i.e.":[114],"Orgentec":[115],"Diagnostika,":[116],"Aesku":[117],"Diagnostics":[118,121],"Inova":[120],"ELISA;":[122],"CliA":[123],"Zenit-RA":[124],"EliA":[126],"Phadia":[127],"Systems).":[129],"A":[130],"further":[131],"30":[132],"samples,":[134],"including":[135],"10":[136,140,147],"healthy":[138],"subjects,":[139],"antiphospholipid":[142],"syndrome":[143],"(APS)":[144],"septic":[149],"assessed":[152],"performance":[157],"limits.":[162],"Reference":[163],"kits":[171],"differ":[172],"among":[173],"values":[178,200],"reported":[179],"by":[180],"manufacturer.":[182],"Moreover,":[183],"normal":[184],"ranges":[186],"calculated":[187],"IgG":[189],"IgM":[191],"differed":[193],"arbitrary":[196],"selected":[197],"classification":[199],"suggested":[201],"guidelines":[204],"40":[206],"GPL":[207],"MPL.":[209]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}